| Literature DB >> 18796561 |
Silvia Cristofanon1, Franck Morceau, A Ivana Scovassi, Mario Dicato, Lina Ghibelli, Marc Diederich.
Abstract
Buthionine sulfoximine (BSO) is a well-known inhibitor of glutathione synthesis, producing slow glutathione (GSH) depletion and oxidative stress; some "responder" cells avoid BSO-induced death by trans-activating the prosurvival protein Bcl-2. Here we show that BSO activates a noncanonical, inhibitory NF-kappaB- and p65-independent NF-kappaB pathway via a multistep process leading to the up-regulation of Bcl-2. The slow BSO-induced GSH depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a p50-p50 homodimer. The early phase, coinciding with substantial thiol depletion, produces a cytosolic preparative complex, consisting of p50 and its interactor Bcl-3 linked by interprotein disulfide bridges. The late phase, coinciding with reactive oxygen species production, is responsible, probably via p38 activation, for nuclear targeting of the complex and trans-activation of Bcl-2.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18796561 DOI: 10.1096/fj.07-104109
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191